About 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide
2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide (PubChem CID 88948640) has the molecular formula C26H24FN5O4
and a molecular weight of 489.51 g/mol. Its IUPAC name is 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide |
| PubChem CID | 88948640 |
| Molecular Formula | C26H24FN5O4 |
| Molecular Weight | 489.51 g/mol |
| Exact Mass | 489.18 |
| IUPAC Name | 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide |
| SMILES | O=C(NO)c1cnc(N2CCN(C(=O)/C(=C/c3ccc4c(c3)CCO4)c3cccc(F)c3)CC2)nc1 |
| InChI | InChI=1S/C26H24FN5O4/c27-21-3-1-2-18(14-21)22(13-17-4-5-23-19(12-17)6-11-36-23)25(34)31-7-9-32(10-8-31)26-28-15-20(16-29-26)24(33)30-35/h1-5,12-16,35H,6-11H2,(H,30,33)/b22-13+ |
| InChIKey | MQABUZMTGBCNNV-LPYMAVHISA-N |
| XLogP | 2.56 |
| TPSA | 107.89 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 489.51 |
| LogP ≤ 5 | 2.56 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'} |
|---|
Analyze 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide?
The IUPAC name of 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide (CID 88948640) is 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide.
What is the SMILES notation for 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide?
The canonical SMILES for 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide is O=C(NO)c1cnc(N2CCN(C(=O)/C(=C/c3ccc4c(c3)CCO4)c3cccc(F)c3)CC2)nc1.
What is the InChIKey of 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide?
The InChIKey is MQABUZMTGBCNNV-LPYMAVHISA-N. The full InChI is InChI=1S/C26H24FN5O4/c27-21-3-1-2-18(14-21)22(13-17-4-5-23-19(12-17)6-11-36-23)25(34)31-7-9-32(10-8-31)26-28-15-20(16-29-26)24(33)30-35/h1-5,12-16,35H,6-11H2,(H,30,33)/b22-13+.
What are the key properties of 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide?
2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide has a molecular weight of 489.51 g/mol, XLogP of 2.56, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[(E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-(3-fluorophenyl)prop-2-enoyl]piperazin-1-yl]-N-hydroxypyrimidine-5-carboxamide is sourced from PubChem (CID 88948640), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).